CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today. Total revenues increased 3% to $65.3 billion, driven by growth
CVS Health Corporation
-(CVS)
XNYS:CVS
CVS Health (NYSE: CVS) Q1 2020 Earnings Call Transcript
CVS Health Corp. (CVS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President, Investor Relations Larry
Infographic: CVS Health Corporation (CVS) Q1 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported first quarter 2020 earnings results today. Total revenues increased 8.3% to $66.8 billion,driven mainly by strong
CVS Health (NYSE: CVS) Q4 2019 Earnings Call Transcript
CVS Health Corp (CVS) Q4 2019 Earnings Conference Call Final Transcript Corporate Participants Valerie C. Haertel Senior Vice President, Investor Relations Officer | CVS Health
Robust earnings from CVS Health in Q4 pushes stock higher
CVS Health (NYSE: CVS) on Wednesday reported fourth-quarter financial results that were stronger than what analysts had anticipated. The company reported earnings
Earnings preview: CVS Health (CVS) poised to deliver stable performance in Q4
The pharmacy retail market is witnessing a major transformation, with traditional drugstore operators adopting technology to keep pace with their online counterparts.
CVS Health Corporation builds on its strong growth in Q3
Building on the strong momentum it has been displaying since the beginning of this year, CVS Health Corporation (NYSE: CVS) on Wednesday
Retailers take strong stand against guns and e-cigs; stocks remain steady
Two of the biggest controversies in recent times have been with regards to guns and e-cigarettes. Several deaths have been caused by
Can Walgreens and CVS Health resist the online invasion of pharmacy sector?
A research report that came out recently predicted that the online pharmacy market is set to grow to $85 billion in the
These deals set a new paradigm for healthcare industry
After a busy 2018, the scale of merger and acquisition activity in the healthcare industry is expected to be high this year
CVS’ stock gains as company lays out growth strategy
CVS Health’s (NYSE: CVS) shares were up 3.2% in afternoon hours as the company outlined its growth strategy and reaffirmed guidance at
CVS Health posts upbeat Q1 earnings, Q2 forecast
CVS Health Corporation (NYSE: CVS) reported a 43% jump in earnings for the first quarter of 2019 helped by the Aetna acquisition
Calendar: Earnings of Alphabet, Pfizer, Merck, Apple, Gilead on queue
Alphabet, Pfizer, Merck, Apple, Gilead Sciences, and more earnings are scheduled for the week between April 29 and May 3. Check out
Earnings preview: Walgreens to benefit from solid prescription volumes in Q2
When Walgreens Boots Alliance (WBA) reports its second-quarter results on April 2 before the opening bell, the market will be looking for
CVS Health reports mixed Q4 results; stock falls over 7%
CVS Health Corporation (CVS) reported better-than-expected earnings for the fourth quarter of 2018 but revenue fell short of estimates, sending the stock
CVS Health Q4 earnings preview: What to expect
CVS Health Corporation (CVS) is scheduled to report fourth-quarter earnings results before the regular trading hours on Wednesday, February 20. The retail
Upcoming earnings for the week Feb 25 to March 1
A slew of major companies are reporting earnings for the week February 25 to March 1. The world’s largest department store chain,
Cardinal Health stock surges above 6% on Q2 earnings beat
Cardinal Health (NYSE: CAH) reported better-than-expected Q2 results primarily driven by better performance from the Pharmaceutical division. The company’s stock jumped above
Walmart, CVS settle pharmacy pricing dispute; ink fresh partnership
In a deal that marks the reunion of two of the world’s largest store operators, Walmart (WMT) and CVS Health (CVS) put
Microsoft-Walgreens deal highlights an emerging trend in healthcare sector
While the healthcare sector is witnessing a dramatic change in the way companies operate, marked by high-profile partnerships, the tech firms joining
Rite Aid stock plunges to 9-year low
Rite Aid (RAD) stock plunged to 9-year lowest of $0.61 on Thursday. Investors remained concerned on the future of the drugstore chain